REFERENCES
- Fox R., Kang H. Pathogenesis of Sjogren's Syndrome. Rheum. Dis. Clin. N. Am. 1992; 18: 517–538
- Hu Y., Nakagawa Y., Purushotham K., Humphreys-Beher M. Functional Changes in Salivary Glands of Autoimmune Disease-Prone NOD Mice. Am. J. Physiol. 1992; 263: E607–614
- Fox P., Speight P. Current Concepts of Autoimmune Exocrinopathy: Immunologic Mechanisms in the Salivary Pathology of Sjogren's Syndrome. Crit. Rev. Oral Biol. Med. 1996; 7: 144–158
- Robinson C., Yamamoto H., Peck A., Humphreys-Beher M. Genetically Programmed Development of Salivary Gland Abnormalities in the NOD (Nonobese Diabetic)-Scid Mouse in the Absence of Detectable Lymphocytic Infiltration: A Potential Trigger for Sialoadenitis of NOD Mice. Clin. Immunol. Immunopathol. 1996; 79: 50–59
- Humphreys-Beher M., Peck A., Dang H., Talal N. The Role of Apoptosis in the Initiation of the Autoimmune Response in Sjogren's Syndrome. Clin. Exp. Immunol. 1999; 116: 383–387
- Hayashi H., Ozono S., Watanabe K., Nagatsu I., Onozuka M. Morphological Aspects of the Postnatal Development of Submandibular Glands in Male Rats: Involvement of Apoptosis. J. Histochem. Cytochem. 2000; 48: 695–698
- Robinson C., Yamachika S., Alford C., Cooper C., Pichardo E., Shah N., Peck A, Humphreys-Beher M. Elevated Levels of Cysteine Protease Activity in Saliva and Salivary Glands of the Nonobese Diabetic (NOD) Mouse Model for Sjogren Syndrome. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 5767–5771
- Kong L., Ogawa N., Nakabayashi T., Liu G., D'Souza E., McGuff H., Guerrero D., Talal N., Dang H. Fas and Fas Ligand Expression in the Salivary Glands of Patients with Primary Sjogren's Syndrome. Arthritis Rheum. 1997; 39: 87–97
- Chao D., Korsmeyer S. BCL-2 Family: Regulators of Cell Death. Annu. Rev. Immunol. 1998; 16: 395–419
- Manganelli P., Quaini F., Andreoli A., Lagrasta C., Pilato F., Zuccarelli A., Monteverdi R., D'Aversa C., Olivetti G. Quantitative Analysis of Apoptosis and bcl-2 in Sjogren's Syndrome. J. Rheumatol. 1997; 24: 1552–1557
- Kong L., Ogawa N., McGuff H., Nakabayashi T., Sakata K., Masago R., Vela-Roch N., Talal N., Dang H. Bcl-2 Family Expression in Salivary Glands from Patients with Primary Sjogren's Syndrome: Involvement of Bax in Salivary Gland Destruction. Clin. Immunol. Immunopathol. 1998; 88: 133–141
- Ryan J., Mantle T., McQuaid S., Costigan D. Salivary Insulin-like Growth Factor-I Originates from Local Synthesis. J. Endocrinol. 1992; 135: 85–90
- Dudek H., Data S., Franke T., Birnbaum M., Yao R., Cooper G., Segal R., Kaplan D., Greenberg M. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt. Science 1997; 275: 661–665
- Peruzzi F., Prisco M., Dews M., Salomoni P., Grassilli E., Romano G., Calabretta B., Baserga R. Multiple Signaling Pathways of the Insulin-like Growth Factor 1 Receptor in Protection from Apoptosis. Mol. Cell. Biol. 1999; 19: 7203–7215
- Datta S., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery. Cell 1997; 91: 231–241
- Suliman I., Lindgren J., Gillberg P., Diab K., Adem A. Effect of Immobilization on Skeletal Muscle Nicotinic Cholinergic Receptors in the Rat. Neuroreport 1997; 8: 2821–2824
- Resnicoff M., Abraham D., Yutanawiboonchai W., Rotman H., Kajstura J., Rubin R., Zoltick P., Baserga R. The Insulin-like Growth Factor I Receptor Protects Tumor Cells from Apoptosis In Vivo. Cancer Res. 1995; 55: 2463–2469
- Lee C., Wu S., Gabrilovich D., Chen H., Nadaf-Rahrov S., Ciernik I., Carbone D. Antitumor Effects of an Adenovirus Expressing Antisense Insulin-like Growth Factor I Receptor on Human Lung Cancer Cell Lines. Cancer Res. 1996; 56: 3038–3041
- McCubrey J., Stillman L., Mayhew M., Algate P., Dellow R., Kaleko M. Growth Promoting Effects of Insulin-like Growth Factor 1 (IGF-1) on Hematopoietic Cells. Overexpression of Introduced IGF-1 Receptor Abrogates Interleukin-3 Dependency of Murine Factor Dependent Cells by Ligand Dependent Mechanism. Blood 1991; 78: 921–929
- Wu Y., Tewari M., Cui S., Rubin R. Activation of the Insulin-like Growth Factor-I Receptor Inhibits Tumor Necrosis Factor-Induced Cell Death. J. Cell. Physiol. 1996; 168: 499–509
- Yang E., Zha J., Jockel J., Boise L., Thompson C., Korsmeyer S. BAD, A Heterodimeric Partner for Bcl-2, Displaces Bax and Promotes Cell Death. Cell 1995; 80: 285–291
- Hayashi Y. Pathogenesis of Sjogren's Syndrome-like Lesions in MRL/lpr Mice. Pathol. Intern. 1994; 44: 559–568
- Johnson E., Jones L., Kozak R. Expression and Function of Insulin-like Growth Factor Receptors on Anti-CD3-activated Human T Lymphocytes. J. Immunol. 1992; 148: 63–71